The resident, identified in inspection records as Resident #12, had been battling symptoms of a UTI when a nurse practitioner ordered urine testing on September 2. But the facility didn't place the lab orders until two days later, on September 4.
The urine sample revealed troubling results. The resident's urine was turbid and tested positive for nitrite, leukocytes, white blood cells, and bacteria. More concerning, the culture identified Escherichia coli extended-spectrum beta-lactamase, or ESBL — an enzyme that makes bacteria resistant to many common antibiotics.
The facility received these critical results on September 7.
Nobody reported them to the ordering practitioner for three more days.
Assistant Director of Nursing #356 finally called the nurse practitioner on September 10, a full week after the resident's symptoms first prompted testing. Only then did the resident receive an antibiotic prescription: Nitrofurantoin monohyd capsules, 100 milligrams twice daily for seven days.
The resident didn't start the medication until September 10, completing the course on September 17.
Federal inspectors found the delay during a complaint investigation at the 108-bed facility. When questioned on November 17, the Director of Nursing said she would need to check what caused the reporting delay. She acknowledged that nurses are expected to report abnormal laboratory results "as soon as possible" to physicians or ordering providers.
The assistant director of nursing who eventually made the call couldn't explain the three-day gap either. She told inspectors she reported the results to the nurse practitioner "when she noticed the lab result had not been reported."
ESBL-producing bacteria pose particular treatment challenges because they resist multiple antibiotics. The enzymes they produce can break down penicillins, cephalosporins, and other commonly prescribed drugs, requiring doctors to use more targeted medications.
For elderly nursing home residents, UTIs can quickly become serious. The resident in this case carried multiple diagnoses including chronic obstructive pulmonary disease, atrial fibrillation, major depressive disorder, hyperlipidemia, anxiety, hypertension, and malignant neoplasm of large intestine.
The facility's own policy, dated June 27, 2024, requires staff to notify physicians and providers when residents need altered medical treatment, including changes in provider orders. The policy specifically states that both the "Physician/Provider and Resident/Family/Responsible Party" must be notified of such changes.
Yet the inspection found a clear breakdown in this basic communication protocol.
The case emerged during two separate complaint investigations, numbered 2657376 and 2614362, suggesting multiple concerns prompted the federal review.
Inspectors reviewed three residents being treated for UTIs at Diplomat Healthcare. Only one case revealed the communication failure, but the pattern raises questions about laboratory result management throughout the facility.
The delay meant the resident spent three additional days with an active, antibiotic-resistant infection while staff possessed the information needed for proper treatment. During those 72 hours, the ESBL-producing E. coli continued multiplying in the resident's urinary system.
The inspection classified the violation as causing "minimal harm or potential for actual harm" affecting "few" residents. But for Resident #12, those three days represented continued discomfort and potential complications from an untreated drug-resistant infection.
The facility's laboratory result management system apparently lacks the safeguards needed to ensure critical findings reach ordering practitioners promptly. Neither the Director of Nursing nor the Assistant Director could explain how culture results indicating antibiotic-resistant bacteria sat unreported for three days.
Federal regulations require nursing homes to obtain laboratory services when ordered and promptly communicate results to ordering practitioners. The requirement exists precisely to prevent situations like the one Resident #12 experienced — where treatment delays allow infections to persist and potentially worsen.
The resident ultimately received appropriate antibiotic therapy and completed the full course. But the case illustrates how communication breakdowns can extend suffering even when facilities eventually provide proper care.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Diplomat Healthcare from 2025-11-25 including all violations, facility responses, and corrective action plans.